Examples of 'summary of product characteristics' in a sentence
Meaning of "summary of product characteristics"
Summary of product characteristics (SPC) is a document that provides essential information about a specific product, most commonly used in the pharmaceutical industry. It outlines the key features, indications, contraindications, dosage, and other relevant information about the product
How to use "summary of product characteristics" in a sentence
Basic
Advanced
summary of product characteristics
Including summary of product characteristics in all languages.
For further information see the summary of product characteristics.
Summary of product characteristics of cobicistat containing products.
Together with the summary of product characteristics.
Summary of product characteristics for a biocidal product family.
Indicate the applied summary of product characteristics.
The summary of product characteristics and the patient information leaflet.
Annex iii amendments to the summary of product characteristics.
See the summary of product characteristics for full details.
Please refer to the current lenalidomide summary of product characteristics.
Annex iii summary of product characteristics.
Amendments in the relevant sections of the summary of product characteristics.
Harmonisation of the summary of product characteristics for authorised antibiotics.
Whether changes imply a significant alteration to the summary of product characteristics.
In the summary of product characteristics.
See also
Amendments to be included in the relevant sections of the summary of product characteristics.
For more details see summary of product characteristics of trastuzumab.
No unauthorised changes must be made to the approved summary of product characteristics.
Annex iii summary of product characteristics and immediate packaging.
This follows the format used in the summary of product characteristics.
Date of the summary of product characteristics and version number.
In the patient package leaflet and in the summary of product characteristics.
Amendment to the summary of product characteristics and package leaflet.
Ad hoc expert group meeting on update of guidance on summary of product characteristics.
Annex ii amendments to summary of product characteristics and package leaflet.
Objectives of therapy are stated in the pharmacodynamic section of the summary of product characteristics.
Please attach the summary of product characteristics.
Details on the recommendations for monitoring patients are found in the summary of product characteristics.
Er summary of product characteristics.
Annex ii amendment to summary of product characteristics.
Summary of product characteristics and package leaflet to be updated after the establishment of DKMA.
The lack of harmonisation of summary of product characteristics for.
The summary of product characteristics will provide detailed recommendations for the use of Zessly.
Grounds for amendment of the summary of product characteristics whereas.
Refer to Summary of Product Characteristics for insulin and metformin for additional information.
Please read this section of the summary of product characteristics very carefully.
Refer to Summary of Product Characteristics for ribavirin and peginterferon alfa for additional information.
Scientific conclusions and grounds for amendment of the summary of product characteristics.
Several sections of the summary of product characteristics were assessed and re worded.
For specific product information always consult the local summary of product characteristics.
Annex iii summary of product characteristics of the reference member state.
The contents of the package leaflet are consistent with the summary of product characteristics.
Amendments to summary of product characteristics and package leaflet relevant sections only.
Grounds for positive opinion and amendment of the summary of product characteristics and package leaflet.
See the Summary of product characteristics here.
Scientific conclusions and grounds for amendment of the summary of product characteristics and package leaflet.
A proposal of Summary of Product Characteristics based on an updated dossier was provided.
Annex II Amendments to relevant sections of the summary of product characteristics and package leaflet.
Refer to the Summary of Product Characteristics of dasabuvir for its pharmacological properties.
Annex IV Amendments to relevant sections of the summary of product characteristics and package leaflet.
You'll also be interested in:
Examples of using Characteristics
Show more
Performance characteristics for diaphragm brake chambers
Differentials for women by background characteristics are minor
Characteristics of the displaced and refugee population
Examples of using Summary
Show more
Summary information relevant to the risk profile
We give a brief summary of these two documents
Summary of the evaluation of the master plan
Examples of using Product
Show more
We certify that the product indicated hereafter
Product serial number displayed on the product
This report is the product of a wide collaboration
